These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 9688124)

  • 1. Reversal of cerebral vasospasm using an intrathecally administered nitric oxide donor.
    Wolf EW; Banerjee A; Soble-Smith J; Dohan FC; White RP; Robertson JT
    J Neurosurg; 1998 Aug; 89(2):279-88. PubMed ID: 9688124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a nitric oxide donor on and correlation of changes in cyclic nucleotide levels with experimental vasospasm.
    Aihara Y; Jahromi BS; Yassari R; Sayama T; Macdonald RL
    Neurosurgery; 2003 Mar; 52(3):661-7; discussion 666-7. PubMed ID: 12590692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of experimental cerebral vasospasm by intracranial delivery of a nitric oxide donor from a controlled-release polymer: toxicity and efficacy studies in rabbits and rats.
    Gabikian P; Clatterbuck RE; Eberhart CG; Tyler BM; Tierney TS; Tamargo RJ
    Stroke; 2002 Nov; 33(11):2681-6. PubMed ID: 12411661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of adenovirus-mediated nitric oxide synthase gene transfer on vasospasm after experimental subarachnoid hemorrhage.
    Stoodley M; Weihl CC; Zhang ZD; Lin G; Johns LM; Kowalczuk A; Ghadge G; Roos RP; Macdonald RL
    Neurosurgery; 2000 May; 46(5):1193-202; discussion 1202-3. PubMed ID: 10807252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release of a nitric oxide donor for the prevention of delayed cerebral vasospasm following experimental subarachnoid hemorrhage in nonhuman primates.
    Clatterbuck RE; Gailloud P; Tierney T; Clatterbuck VM; Murphy KJ; Tamargo RJ
    J Neurosurg; 2005 Oct; 103(4):745-51. PubMed ID: 16266059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of intrathecal sodium nitroprusside on severe chronic vasospasm.
    Egemen N; Türker RK; Sanlidilek U; Zorlutuna A; Bilgiç S; Baskaya M; Unlü A; Caglar S; Spetzler RF; McCormick JM
    Neurol Res; 1993 Oct; 15(5):310-5. PubMed ID: 7905604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of the endothelin-A receptor antagonist TBC 11251 attenuates cerebral vasospasm after experimental subarachnoid hemorrhage: dose study and review of endothelin-based therapies in the literature on cerebral vasospasm.
    Wanebo JE; Arthur AS; Louis HG; West K; Kassell NF; Lee KS; Helm GA
    Neurosurgery; 1998 Dec; 43(6):1409-17; discussion 1417-8. PubMed ID: 9848855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of intrathecal magnesium sulfate solution injection via a microcatheter in the cisterna magna on cerebral vasospasm in the canine subarachnoid haemorrhage model.
    Mori K; Yamamoto T; Miyazaki M; Hara Y; Aiko Y; Koike N; Sakamoto S; Nakao Y; Esaki T
    Br J Neurosurg; 2012 Feb; 26(1):64-8. PubMed ID: 21767131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of intrathecal liposomal fasudil for experimental cerebral vasospasm after subarachnoid hemorrhage.
    Takanashi Y; Ishida T; Meguro T; Kiwada H; Zhang JH; Yamamoto I
    Neurosurgery; 2001 Apr; 48(4):894-900; discussion 900-1. PubMed ID: 11322450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal urokinase infusion through a microcatheter into the cisterna magna to prevent cerebral vasospasm: experimental study in dogs.
    Mizuno T; Hamada J; Kai Y; Todaka T; Morioka M; Ushio Y
    AJNR Am J Neuroradiol; 2003 Apr; 24(4):613-8. PubMed ID: 12695190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of recombinant streptokinase on the development of chronic cerebral vasospasm after subarachnoid hemorrhage in a swine model.
    Xu H; Chen X; Qin Z; Gu Y; Zhou P
    Acta Neurochir (Wien); 2011 Jun; 153(6):1333-8; discussion 1338. PubMed ID: 21311917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal cerebrospinal fluid magnesium ion concentration for vasodilatory effect and duration after intracisternal injection of magnesium sulfate solution in a canine subarachnoid hemorrhage model.
    Mori K; Yamamoto T; Miyazaki M; Hara Y; Aiko Y; Koike N; Sakamoto S; Nakao Y; Esaki T
    J Neurosurg; 2011 Apr; 114(4):1168-75. PubMed ID: 21073257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of delayed cerebral vasospasm by continuous intrathecal infusion of glyceroltrinitrate and nimodipine in the rabbit model in vivo.
    Marbacher S; Neuschmelting V; Graupner T; Jakob SM; Fandino J
    Intensive Care Med; 2008 May; 34(5):932-8. PubMed ID: 18214428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and reversal of experimental posthemorrhagic vasospasm by the periadventitial administration of nitric oxide from a controlled-release polymer.
    Tierney TS; Clatterbuck RE; Lawson C; Thai QA; Rhines LD; Tamargo RJ
    Neurosurgery; 2001 Oct; 49(4):945-51; discussion 951-3. PubMed ID: 11564257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective improvement of the cerebral vasospasm after subarachnoid hemorrhage with low-dose nitroglycerin.
    Ito Y; Isotani E; Mizuno Y; Azuma H; Hirakawa K
    J Cardiovasc Pharmacol; 2000 Jan; 35(1):45-50. PubMed ID: 10630732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal and prevention of cerebral vasospasm by intracarotid infusions of nitric oxide donors in a primate model of subarachnoid hemorrhage.
    Pluta RM; Oldfield EH; Boock RJ
    J Neurosurg; 1997 Nov; 87(5):746-51. PubMed ID: 9347984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans.
    Thomas JE; Rosenwasser RH
    Neurosurgery; 1999 Jan; 44(1):48-57; discussion 57-8. PubMed ID: 9894963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous intrathecal glyceryl trinitrate prevents delayed cerebral vasospasm in the single-SAH rabbit model in vivo.
    Fathi AR; Marbacher S; Graupner T; Wehrli F; Jakob SM; Schroth G; Fandino J
    Acta Neurochir (Wien); 2011 Aug; 153(8):1669-75; discussion 1675. PubMed ID: 21671141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effect of L-arginine and superoxide dismutase on the spastic basilar artery after subarachnoid hemorrhage in dogs.
    Kajita Y; Suzuki Y; Oyama H; Tanazawa T; Takayasu M; Shibuya M; Sugita K
    J Neurosurg; 1994 Mar; 80(3):476-83. PubMed ID: 8113861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed intracranial delivery of a nitric oxide donor from a controlled-release polymer prevents experimental cerebral vasospasm in rabbits.
    Pradilla G; Thai QA; Legnani FG; Hsu W; Kretzer RM; Wang PP; Tamargo RJ
    Neurosurgery; 2004 Dec; 55(6):1393-9; discussion 1399-1400. PubMed ID: 15574221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.